What this is
- How it works
- How it works isn't classified yet
- Tested for
- Infertility, Female
- Main trialPhase 1
- “The goal of this Interventional study is to Compare the Pharmacokinetics and Safety of Recombinant Human Follicle Stimulating Hormone Injection (QL1012D) and Gonal-F® in Healthy Female Volunteers. It aims to evaluate the bioequivalence of recombinant human follicle stimulating hormone injection (QL1012D) and Gonal-F®, both given subcutaneously.”In the company’s words, NCT06864793 on ClinicalTrials.gov
- Other names
- Follitropin alfa
- Copy of
- Gonal-F (EMD Serono)Tested side by side with the original in NCT06864793
Other drugs for Infertility, Female
- MibavademabRegeneron · Phase 2
- SJ04Suzhou Centergene Pharmaceuticals Co.,Ltd. · Phase 1
- Fang Le ShuLG Chem · Marketed (Phase 4 trial)
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Active, not recruiting | 4 Feb 2026 | Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026